CathWorks logo — Improving the health of patients by transforming how cardiov...

CathWorks

Improving the health of patients by transforming how cardiovascular disease is diagnosed and treated.

Founded 2013 United States Newport Beach, United States 84 employees Corporate Round Total: $154.40M Health Care, Medical Devices

General Information

Company Name CathWorks
Founded Year 2013
Location United States Newport Beach, United States +4
Employees 84
Industries Health Care, Medical Devices
Funding Stage Corporate Round
Social

Get notified when CathWorks moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CathWorks

CathWorks is a healthcare startup founded in 2013 with a clear mission outlined in its slogan – "Improving the health of patients by transforming how cardiovascular disease is diagnosed and treated." This Israel-based medical technology company is dedicated to revolutionizing the approach to diagnosing and treating Coronary Artery Disease (CAD). CathWorks leverages an advanced computational science platform to elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians. Their focus on bringing the CathWorks FFRangio™ System to market reflects a commitment to providing quick, precise, and objective intraprocedural wire-free FFR guidance that is practical for every case. The latest milestone for CathWorks came with a significant $75.00M Corporate Round investment on 12 July 2022, which was led by Medtronic. This injection of capital not only signifies confidence in the company's vision and technology but also serves as validation for the potential impact of their solutions in the realm of cardiovascular disease diagnosis and treatment.

Taxonomy: Medical Technology, Cardiovascular Disease, Coronary Artery Disease, FFR-guided PCI, Computational Science, Healthcare Innovation, Non-invasive Technology, Intraprocedural Guidance

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round •••••• 1 •••• •••• 12 Jul 2022
Series D •••••• - 11 Jan 2021
Grant •••••• 1 •••• •••• 30 May 2019
Series C •••••• 1 •••• •••• 05 Feb 2019
Series B •••••• 6
Investor Investor Investor Investor Investor
•••• ••••
02 Oct 2017

CathWorks Alternatives & Competitors

CathWorks vs

Leading the way in non-invasive cardiac diagnostics with advanced Computational Fluid Dynamics techn...

Seed
51-200 employees
Health Care, Life Sciences
CathWorks vs

Restoring flow of ACTIVE life..... one artery at a time

Series A
4 employees
Health Care, Manufacturing
CathWorks vs

Pioneering the future of cardiovascular health with innovative miRNA biomarkers to enhance diagnosis...

Series Unknown
Biotechnology, Health Care

FAQ About CathWorks

Improving the health of patients by transforming how cardiovascular disease is diagnosed and treated.
CathWorks was founded in 2013.
CathWorks is headquartered in Newport Beach, United States.
CathWorks operates in the following industries: Health Care, Medical Devices.
CathWorks has approximately 84 employees.
CathWorks has completed 5 funding rounds, raising a total of $154.40M. The latest funding stage is Corporate Round.
Top alternatives and competitors to CathWorks include Life Flow, Soundbite Medical Solutions Inc., Mirnext, HEMOLENS DIAGNOSTICS, Health BETA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CathWorks and Life Flow are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CathWorks and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy